Evidence‐based recommendations for the diagnosis and management of rheumatoid arthritis for non‐rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Rheumatic Diseases

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1756-185X.12905PMID 27452207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive Value

  2020cited by this paper
• Where do patients with MRI-confirmed single-level radiculopathy experience pain, and what is the clinical interpretability of these pain patterns? A cross-sectional diagnostic accuracy study

  2019cited by this paper
• Celecoxib for rheumatoid arthritis.

  2017cited by this paper
• Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial

  2014cited by this paper
• Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis.

  2014cited by this paper
• GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate

  2013cited by this paper
• Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany).

  2013cited by this paper
• Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI)

  2013cited by this paper
• Prevalence and risk factors for chloroquine maculopathy and role of plasma chloroquine and desethylchloroquine concentrations in predicting chloroquine maculopathy

  2013cited by this paper
• Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis

  2013cited by this paper
• High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis

  2013cited by this paper
• Association of hepatitis B with antirheumatic drugs: a case–control study

  2013cited by this paper
• The new 2012 German recommendations for treating rheumatoid arthritis

  2013cited by this paper
• Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study

  2013cited by this paper
• Anaemia to predict radiographic progression in rheumatoid arthritis

  2013cited by this paper
• Treating to a Target in Established Active Rheumatoid Arthritis Patients Receiving a Tumor Necrosis Factor Inhibitor: Results From a Real‐World Cluster‐Randomized Adalimumab Trial

  2013cited by this paper
• Anaemia to predict radiographic progression in rheumatoid arthritis

  2013cited by this paper
• A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.

  2012cited by this paper
• Diagnostic value of antibodies to modified citrullinated vimentin in early rheumatoid arthritis.

  2012cited by this paper
• Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort

  2012cited by this paper
• Adverse effects of low dose methotrexate in rheumatoid arthritis patients.

  2012cited by this paper
• Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort

  2012cited by this paper
• Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort

  2012cited by this paper
• Comparison of the 1987 ACR criteria and the 2010 ACR/EULAR criteria in an inception cohort of patients with recent-onset inflammatory polyarthritis.

  2012cited by this paper
• Comparison of ACR 1987 and ACR/EULAR 2010 criteria for predicting a 10-year diagnosis of rheumatoid arthritis.

  2012cited by this paper
• Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?

  2012cited by this paper
• Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials.

  2012cited by this paper
• Hepatitis C virus infection associated arthritis.

  2012cited by this paper
• [Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome].

  2011cited by this paper
• Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria.

  2011cited by this paper
• Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital.

  2011cited by this paper
• Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study

  2011cited by this paper
• The effects of strength and endurance training in patients with rheumatoid arthritis

  2011cited by this paper
• Physical activity coaching of patients with rheumatoid arthritis in everyday practice: a long-term follow-up.

  2011cited by this paper
• Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression

  2011cited by this paper
• Effects of a Group-Based Exercise and Educational Program on Physical Performance and Disease Self-Management in Rheumatoid Arthritis: A Randomized Controlled Study

  2011cited by this paper
• Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

  2011cited by this paper
• Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort

  2011cited by this paper
• Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria

  2011cited by this paper
• Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs

  2011cited by this paper
• Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.

  2011cited by this paper
• Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria.

  2011cited by this paper
• The Value of Conventional Radiographs in Undifferentiated Arthritis: A Systematic Review

  2011cited by this paper
• Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide

  2011cited by this paper
• Diagnostic Accuracy of ACR/EULAR 2010 Criteria for Rheumatoid Arthritis in a 2-Year Cohort

  2011cited by this paper
• Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis

  2011cited by this paper
• Opioid therapy for treating rheumatoid arthritis pain.

  2011cited by this paper
• Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study

  2011cited by this paper
• Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study

  2010cited by this paper
• Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians

  2010cited by this paper
• The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I

  2010cited by this paper
• Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients.

  2010cited by this paper
• UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha,

  2010cited by this paper
• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

  2010cited by this paper
• A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

  2010cited by this paper
• Prevalence and characteristics of articular manifestations in human immunodeficiency virus infection.

  2010cited by this paper
• Serum uric acid and self-reported rheumatoid arthritis in a multiethnic adult female population

  2010cited by this paper
• A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.

  2009cited by this paper
• DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis

  2009cited by this paper
• Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis.

  2009cited by this paper
• Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis

  2009cited by this paper
• Chronic Kidney Disease – Guideline edited by the National Collaborating Centre for Chronic Conditions

  2009cited by this paper
• Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).

  2009cited by this paper
• Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.

  2009cited by this paper
• The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials

  2009cited by this paper
• The Rheumatoid Arthritis Disease Activity Index-5 in Daily Use. Proposal for Disease Activity Categories

  2009cited by this paper
• Supervised aerobic exercise is more effective than home aerobic exercise in female chinese patients with rheumatoid arthritis.

  2009cited by this paper
• Extra-articular manifestations of rheumatoid arthritis: a hospital-based study

  2009cited by this paper
• Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis

  2009cited by this paper
• Coaching patients with early rheumatoid arthritis to healthy physical activity: a multicenter, randomized, controlled study.

  2008cited by this paper
• The problem of rheumatoid arthritis disease activity and remission in clinical practice.

  2008cited by this paper
• Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.

  2008cited by this paper
• Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.

  2008cited by this paper
• Levels of Evidence

  2008cited by this paper
• Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports

  2008cited by this paper
• Clinical significance of anti-Ro antibodies in rheumatoid arthritis

  2008cited by this paper
• Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.

  2008cited by this paper
• RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories

  2008cited by this paper
• Systemic Lupus Erythematosus Features in Rheumatoid Arthritis and Their Effect on Overall Mortality

  2008cited by this paper
• Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.

  2007cited by this paper
• Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis.

  2007cited by this paper
• Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.

  2007cited by this paper
• Management of early rheumatoid arthritis.

  2007cited by this paper
• Gross synovial fluid analysis in the differential diagnosis of joint effusion

  2007cited by this paper
• Assessing remission in clinical practice.

  2007cited by this paper
• Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China.

  2007cited by this paper
• Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative

  2007cited by this paper
• Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience

  2007cited by this paper
• Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.

  2007cited by this paper
• Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

  2007cited by this paper
• Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

  2007cited by this paper
• Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.

  2006cited by this paper
• British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).

  2006cited by this paper
• Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

  2006cited by this paper
• EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

  2006cited by this paper
• Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis.

  2006cited by this paper
• Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren’s syndrome

  2006cited by this paper
• Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids

  2006cited by this paper
• Rheumatic manifestations of human immunodeficiency virus infection.

  2006cited by this paper
• Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.

  2006cited by this paper

• What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines

  2023cites this paper
• Efficacy and safety of biologic, biosimilars and targeted synthetic DMARDs in moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: a systematic review and network meta-analysis

  2023influential citation
• Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases

  2021cites this paper
• Influences of miR-320 a on proliferation and apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis through targeting MAPK-ERK 1 / 2

  2019cites this paper
• Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial

  2019cites this paper
• Health-related quality of life in patients with rheumatoid arthritis

  2019cites this paper
• 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in patients with rheumatoid arthritis

  2017cites this paper